Skip to main content

Table 7 Comparison of pregnancy outcomes between women with GDM A1, GDM A2, and PGDM

From: Clinical analysis of 2860 cases of diabetes in pregnancy: a single-center retrospective study

Variable

GDM A1 group (N = 2305)

GDM A2 group (N = 215)

PGDM group (N = 340)

χ2 value

P value

Premature delivery

515 (22.34%)#

55 (25.58%)#*

107 (31.47%)*

14.13

< 0.05

Stillbirth

14 (0.61%)

0

2 (0.59%)

 

0.787a

SGA

485 (21.04%)

52 (24.19%)

76 (22.35%)

1.35

0.509

LGA

83 (3.60%)#

6 (2.79%)#*

24 (7.06%)*

10.16

< 0.05

Congenital anomalies

212 (9.20%)

21 (9.77%)

35 (10.29%)

0.46

0.793

Neonatal asphyxia

175 (7.59%)

14 (6.51%)

37 (10.88%)

5.03

0.081

NICU transfer

317 (13.75%)#

33 (15.35%)#

81 (23.82%)*

23.49

< 0.05

Cesarean section

1186 (51.45%)#

126 (58.60%)#*

226 (66.47%)*

29.06

< 0.05

Assisted vaginal delivery

15 (0.65%)

2 (0.93%)

6 (1.76%)

 

0.076a

PPH

219 (9.50%)

17 (7.91%)

30 (8.82%)

0.67

0.706

Puerperal infection

134 (5.18%)

14 (6.51%)

25 (7.35%)

1.32

0.516

Maternal ICU transfer

21 (0.91%)

0 (0.00%)

6 (1.76%)

 

0.115a

Neonatal hypoglycemia

34 (1.48%)#

5 (2.33%)#*

12 (3.53%)*

 

< 0.05a

Neonatal hyperbilirubinemia

28 (1.21%)

1 (0.47%)

2 (0.59%)

 

0.536a

  1. GDM Gestational diabetes mellitus, PGDM Pregestational diabetes mellitus, SGA small for gestational age, LGA Large for gestational age, NICU Neonatal intensive care unit, PPH Postpartum hemorrhage, ICU Intensive care unit
  2. Note: Similar symbols between two groups indicate that the difference between the groups was not statistically significant; different symbols between two groups indicate statistically significant difference
  3. aindicates the use of the Fisher exact test